Therapy | MO | Median (IQR) % live cells | Median (IQR) % reduction of live cells | P value | Median (IQR) log10 cfu/ml* | Median (IQR) % reduction** of cfu/ml* | P value | ||
---|---|---|---|---|---|---|---|---|---|
C+ | ALT | C+ | ALT | ||||||
Treatment | P. aeruginosa | 88.9 (84.4–93.4) | 39.3 (30.1–50.9) | 53.2 (39.4–64.1) | < 0.001 | 7.5 (7.4– b) | -a | 100.0 (100.0–100.0) | 0.002 |
E. coli | 55.9 (49.6–67.3) | 18.8 (12.5–31.2) | 67.9 (46.7–78.7) | 0.002 | 7.0 (6.7–7.4) | -a | 100.0 (100.0–100.0) | 0.002 | |
S. aureus | 42.9 (28.7–57.5) | 0.0 (0.0–0.0) | 100.0 (100.0–100.0) | 0.007 | 7.7 (7.5–7.9) | -a | 100.0 (100.0–100.0) | 0.002 | |
Prophylaxis | P. aeruginosa | 83.1 (77–88.4) | 0.0 (0.0–0.0) | 100.0 (100.0–100.0) | < 0.001 | 7.4 (6.9–8.4) | -a | **Absence | 0.004 |
E. coli | 43.9 (34.1–46.1) | 0.0 (0.0–0.0) | 100.0 (100.0–100.0) | <0.001 | 7.2 (6.9–7.34) | -a | **Absence | 0.002 | |
S. aureus | 32.7 (23.7–49.7) | 0.0 (0.0–0.0) | 100.0 (100.0–100.0) | 0.008 | 7.6 (7.4–7.8) | -a | **Absence | 0.002 |